The "invisible proteome": How to capture the low-abundance proteins via combinatorial ligand libraries

Current Proteomics

Volumn 4, Issue 4, 2007, Pages 198-208

  Boschetti, Egisto ^a   Monsarrat, Bernard ^b   Righetti, Pier Giorgio ^c  

^a CEA SACLAY   (France)

^b INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^c POLITECNICO DI MILANO   (Italy)

Author keywords

Cerebrospinal fluid; E. coli proteome; Ligand library; Peptide ligands; Platelets; Rare proteome; Red blood cells; S. cerevisiae proteome

Indexed keywords

ESCHERICHIA COLI; SACCHAROMYCES CEREVISIAE;

EID: 37549041716     PISSN: 15701646     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016407783221277     Document Type: Review

References (52)

1. Antonioli, P., Fortis, F., Guerrier, L., Rinalducci, S., Zolla, L., Righetti, P.G. and Boschetti, E. (2007). Capturing and amplifying impurities from purified recombinant monoclonal antibodies via peptide library beads: A proteomic study. Proteomics 7: 1624-33.
2. Baggerly, K.A., Morris, J.S., Edmonson, S.R. and Coombes, K.R. (2005). Signal in noise: Evaluating reported reproducibility of serum proteomic tests for ovarian cancer. J. Natl. Cancer Inst. 97: 307-9.
3. Bhattacharya, D., Mukhopadhyay, D. and Chakrabarti, A. (2007). Hemoglobin depletion from red blood cell cytosol reveals new proteins in 2-D gel-based proteomics study. Proteomics Clin. Appl. 1: 561-4.
4. Boschetti, E., Lomas, L., Citterio, A. and Righetti, P.G. (2007). Romancing the "hidden proteome", Anno Domini two zero zero seven. J. Chromatogr. A. 1277-90.
5. Cao, Z., Suljak, W. and Tan, W. (2005). Molecular beacon aptamers for protein monitoring in real-time and in homogeneous solutions. Curr. Proteomics 2: 31-40.
6. Castagna, A., Cecconi, D., Sennels, L., Rappsilber, J., Guerrier, L., Fortis, F., Boschetti, E., Lomas, L., et al. (2005). Exploring the hidden human urinary proteome via ligand library beads. J. Proteome Res. 4: 1917-30.
7. de Godoy, L.M., Olsen, J.V., de Souza, G.A., Li, G., Mortensen, P. and Mann, M. (2006). Status of complete proteome analysis by mass spectrometry: SILAC labelled yeast as a model system. Genome. Biol. 7: R50-R60.
8. Finehout, E.J., Franck, Z., Choe, L.H., Relkin, N. and Lee, K.H. (2007). Cerebrospinal fluid proteomic biomarkers for Alzheimer's disease. Ann. Neurol. 61: 120-9.
9. Fitzgerald, D.J. (2001). Vascular biology of thrombosis: the role of platelet-vessel wall adhesion. Neurology 57: S1-S4.
10. Fortis, F., Guerrier, L., Righetti, P.G., Antonioli, P. and Boschetti, E. (2006a). A new approach for the removal of protein impurities from purified biologicals using combinatorial solid-phase ligand libraries. Electrophoresis 27: 3018-27.
11. Fortis, F., Guerrier, L., Areces, L.B., Antonioli, P., Hayes, T., Carrick, K., Hammond, D., Boschetti, E., et al. (2006b). A new approach for the detection and identification of protein impurities using combinatorial solid phase ligand libraries. J. Proteome Res. 5: 2577-85.
12. Garcia, A., Prabhakar, S., Brock, C.J., Pearce, A.C., Dwek, R.A., Watson, S.P., Hebestreit, H.F. and Zitzmann, N. (2004). Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4: 656-68.
13. Gevaert, K., Goethals, M., Martens, L., Van Damme, J., Staes, A., Thomas, G.R. and Vandekerckhove, J. (2003). Exploring proteomes and analyzing protein processing by mass spectrometric identification of sorted N-terminal peptides. Nat. Biotechnol. 21: 566-9.
14. Gevaert, K., Ghesquiere, B., Staes, A., Martens, L., Van Damme, J., Thomas, G.R. and Vandekerckhove, J. (2004). Reversible labelling of cysteine-containing peptides allows their specific chromatographic isolation for non-gel proteome studies. Proteomics 4: 897-908.
15. Guerrier, L., Thulasiraman V., Castagna, A., Fortis, F., Lin, S., Lomas, L., Righetti, P.G. and Boschetti, E. (2006). Reducing protein concentration range of biological samples using solid-phase ligand libraries. J. Chromatogr. B. 833: 33-40.
16. Guerrier, L., Claverol, S., Fortis, F., Rinalducci, S., Timperio, A.M., Antonioli, P., Jandrot-Perrus, M., Boschetti, E., et al. (2007). Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. J. Proteome Res. 6: 4290-303.
17. Herbert, B., Pedersen, S.K., Harry, J.L., Sebastian, L., Grinyer, J., Traini, M.D., McCarthy, J.T., Wilkins, M.R., et al. (2003) Mastering proteome complexity using two-dimensional gel electrophoresis. PharmaGenomics 3: 22-36.
18. Hu, S., Loo, J.A. and Wong, D.T. (2006). Human body fluid proteome analysis. Proteomics 6: 6326-53.
19. Huan, J.T., McKenna, T., Hughes, C., Leweke, F.M., Schwarz, E. and Bahn, S. (2007). CSF biomarker discovery using label-free nano-LC-MS based proteomic profiling: technical aspects. J. Sep. Sci. 30: 214-25.
20. Inagaki, N. and Katsuta, K. (2004). Large gel two-dimensional electrophoresis: improving recovery of cellular proteome. Curr. Proteomics 1: 35-9.
21. Jessani, N., Liu, Y., Humphrey, M. and Cravatt, B. F. (2002). Enzyme activity profiles of the secreted and membrane proteome that depict cancer cell invasiveness. Proc. Natl. Acad. Sci. USA 99: 10335-4.
22. Jin, T., Hu, L.S., Chang, M., Wu, J., Winblad, B. and Zhu, J. (2007). Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur. J. Neurol. 14: 563-8.
23. Kakhniashvili, D.G., Bulla, L.A. Jr. and Goodman, S.R. (2004). The human erythrocyte proteome. Analysis by ion-trap mass spectrometry. Mol. Cell. Proteomics 3: 501-9.
24. Khwaja, F.W., Reed, M.S., Olson, J.J., Schmotzer, B.J., Gillespie, G.Y., Guha, A., Groves, M.D., Kesari, S., et al. (2007). Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients. J. Proteome Res. 6: 559-70.
25. Klose, J. and Zeindl, E. (1984). An attempt to resolve all the various proteins in a single human cell type by two dimensional electrophoresis. I: extraction of all cell proteins. Clin. Chem. 30: 2014-20.
26. Lathrop, J.T., Fijalkowska, I. and Hammond, D. (2007). The Bead blot: A method for identifying ligand-protein and protein-protein interactions using combinatorial libraries of peptide ligands. Anal. Biochem. 361: 65-76.
27. Leung, D., Hardouin, C., Boger, D. L. and Cravatt, B. F. (2003). Discovering potent and selective reversible inhibitors of enzymes in complex proteomes. Nat. Biotechnol. 21: 687-91.
28. Martens, L., Van Damme, P., Van Damme, J., Staes, A., Timmerman, E., Ghesquiere, B., Thomas, G.R., Vandekerckhove, J., et al. (2005). The human platelet proteome mapped by peptide-centric proteomics: a functional protein profile. Proteomics 5: 3193-204.
29. O'Neil, E.E., Brock, C.J., von Kriegsheim, A.F., Pearce, A.C., Dwek, R.A., Watson, S.P. and Hebestreit, H.F. (2002). Towards complete analysis of the platelet proteome. Proteomics 2: 288-305.
30. Pasini, E.M., Kerkegaaard, M., Mortesen, P., Lutz, H.U., Thomas, A.W. and Mann, M. (2006). In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108: 791-801.
31. Patterson, S. D. (2004). How much of the proteome do we see with discovery-based proteomics methods and how much do we need to see? Curr. Proteomics 1: 3-12.
32. Patterson, S. D. and Aebersold, R. H. (2003). Proteomics: the first decade and beyond. Nat. Genet. 33: 311-23.
33. Patterson, S. D. and Latter, G. I. (1993). Evaluation of storage phosphor imaging for quantitative analysis of 2-D gels using the Quest II system. BioTechniques 15: 1076-83.
34. Pedersen, S.K., Harry, J.L., Sebastian, L., Baker, J., Traini, M.D., McCarthy, J.T., Manoharan, A., Wilkins, M.R., et al. (2003). Unseen proteome: mining below the tip of the iceberg to find low abundance and membrane proteins. J. Proteome Res. 2: 303-12.
35. Peng, J., Elias, J. E., Thoreen, C. C., Licklider, L. J. and Gygi, S. P. (2003). Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: the yeast proteome. J. Proteome Res. 2: 43-50.
36. Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., et al. (2002a). Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-7.
37. Petricoin, E. F., Mills, G. B., Kohn, E. C. and Liotta, L. A. (2002b). Proteomic patterns in serum and identification of ovarian cancer. Lancet 360: 170-1.
38. Pieper, R., Gatlin, C. L., Makusky, A. J., Russo, P. S., Schatz, C. R., Miller, S. S., Su, Q., McGrath, A. M., et al. (2003a). The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3: 1345-64.
39. Pieper, R., Su, Q., Gatlin, C. L., Huang, S. T., Anderson, N. L. and Steiner, S. (2003b). Multi-component immunoaffinity subtractionchromatography: An innovative step towards a comprehensive survey of the human plasma proteome. Proteomics 3: 422-32.
40. Righetti, P.G., Castagna, A., Herbert, B., Reymond, F. and Rossier, J.S. (2003). Prefractionation techniques in proteome analysis. Proteomics 3: 1397-407.
41. Righetti, P.G., Castagna, A., Herbert, B. and Candiano, G. (2005a). How to bring the "unseen" proteome to the limelight via electrophoretic prefractionation techniques. Biosci. Rep. 25: 3-17.
42. Righetti, P.G., Castagna, A., Antonioli, P. and Boschetti, E. (2005b). Prefractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 26: 297-319.
43. Righetti, P.G., Castagna, A., Antonucci, F., Piubelli, C., Cecconi, D., Campostrini, N., Rustichelli, C., Antonioli, P., et al. (2005c). Proteome analysis in the clinica chemistry laboratory: myth or reality? Clin. Chim. Acta 357: 123-39.
44. Righetti, P.G., Boschetti, E., Lomas, L. and Citterio, A. (2006). Protein Equalizer technology: the quest for a "democratic proteome". Proteomics 6: 3980-92.
45. Righetti, P.G. and Boschetti, E. (2007). Sherlock Holmes and the proteome - a detective story. FEBS J. 274: 897-905.
46. Sennels, L., Salek, M., Lomas, L., Boschetti, E., Righetti, P.G. and Rappsilber, J. (2007). Proteomic analysis of human blood serum using peptide library beads. J. Proteome Res. 6: 4055-62.
47. Simonsen, A.H., McGuire, J., Hansson, O., Zetterberg, H., Podust, V.N., Davies, H.A., Waldemar, G., Minthon, L., et al. (2007). Novel panel of cerebrospinal fluid biomarkers for the prediction of progression to Alzheimer dementia in patients with mild cognitive impairment. Arch Neurol. 64: 366-70.
48. Thulasiraman, V., Lin, S., Gheorghiu, L., Lathrop, J., Lomas, L., Hammond, D. and Boschetti, E. (2005). Reduction of the concentration difference of proteins in biological liquids using a library of combinatorial ligands. Electrophoresis 26: 3561-71.
49. Villanueva, J., Philip, J., Entenberg, D., Chaparro, C.A., Tanwar, M.K., Holland, E.C. and Tempst, P. (2004). Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. Anal. Chem. 76: 1560-70.
50. Walnesky, L.D., Narla, M. and Lux IV, S.E. (2003). Disorders of the red blood cell membrane, in Handin, R.I., Lux, IV, S.E., Stossel, P.T., eds., Blood: Principle and Practice of Haematology, Lippincott, pp. 1709-858.
51. Washburn, M.P., Wolters, D. and Yates, J.R. III. (2001). Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19: 242-7.
52. Young, D. (1984). Advantages of separations on "giant" two-dimensional gels for detection of physiologically relevant changes in the expression of protein-gene products. Clin. Chem. 30: 2104-8.